gastric-cancer

Documents about gastric-cancer

• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction#992390ClinicalTrials.gov
• Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer#812311ClinicalTrials.gov
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach#979733ClinicalTrials.gov
• Surgery for Obstructed Gastric Carcinoma#836019ClinicalTrials.gov
• Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial#825660ClinicalTrials.gov
• Novel Approach to Surveillance of Gastric Lesions#834351ClinicalTrials.gov
• Predicting Biomarker of Gastric Cancer Chemotherapy Response#837432ClinicalTrials.gov
• Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer#842920ClinicalTrials.gov
• Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer#865689ClinicalTrials.gov
• Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer#878733ClinicalTrials.gov
• Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)#839882ClinicalTrials.gov
• Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis#891050ClinicalTrials.gov
• Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer#1007380ClinicalTrials.gov
• Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens#125840ClinicalTrials.gov
• GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer#321697ClinicalTrials.gov
• Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer#674894ClinicalTrials.gov
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer#806123ClinicalTrials.gov
• 18F-FAPI PET/CT and MRI in Gastric Cancer#812793ClinicalTrials.gov
• Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer#831880ClinicalTrials.gov
• FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer#847899ClinicalTrials.gov
• Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer#859463ClinicalTrials.gov
• Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers#889160ClinicalTrials.gov
• D1 vs D2 Lymphadenectomy in Gastric Cancer#907605ClinicalTrials.gov
• A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)#628527ClinicalTrials.gov
• A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma#856619ClinicalTrials.gov
• Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach#918082ClinicalTrials.gov
• Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients#982707ClinicalTrials.gov
• Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy#843337ClinicalTrials.gov
• HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis#871761ClinicalTrials.gov
• Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer#894661ClinicalTrials.gov
• PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.#915311ClinicalTrials.gov
• Gastrectomy Outcomes in Elderly Patients#890073ClinicalTrials.gov
• Management of gastric cancer peritoneal metastasis: International Gastric Cancer Association GCPM Working Group consensus statements.#15203NCBI PubMed Central
• HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis#172321ClinicalTrials.gov
• A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer#373595ClinicalTrials.gov
• Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy#407738ClinicalTrials.gov
• Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer#863425ClinicalTrials.gov
• BLI for the Diagnosis of Precancerous Conditions#876905ClinicalTrials.gov
• Identification of Therapeutic Targets in Metastatic Gastric Cancer#883517ClinicalTrials.gov
• Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway#885076ClinicalTrials.gov
• PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer#889180ClinicalTrials.gov
• Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy#890898ClinicalTrials.gov
• Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)#894301ClinicalTrials.gov
• Blood Tests for Gastritis and Gastric Neoplasms#902811ClinicalTrials.gov
• Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer#915279ClinicalTrials.gov
• Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer#1007375ClinicalTrials.gov
• Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors#913397ClinicalTrials.gov
• TAS102 in Combination With NAL-IRI in Advanced GI Cancers#894416ClinicalTrials.gov
• Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality#863880ClinicalTrials.gov
• RCT of Gastric ESD With or Without Epineprhine Added Solution#826004ClinicalTrials.gov